Trial Outcomes & Findings for Study of Novel Approaches for Prevention (NCT NCT01183689)

NCT ID: NCT01183689

Last Updated: 2020-01-14

Results Overview

Mean weight change from baseline across an average planned follow-up of three years. These mean changes will be compared among the three arms of the trial.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

599 participants

Primary outcome timeframe

3 years

Results posted on

2020-01-14

Participant Flow

SNAP targeted an enrollment of 600 participants, aged 18-35 years, with a BMI of 21.0 to 30.9. Participants were recruited from 2 clinical sites (Providence, RI and Chapel Hill, NC). The final sample of 599 participants (27% minority, 22% male) was recruited over a 19-month period (Aug 2010-Feb 2012).

Participants were pre-screened online and by telephone before attending an orientation, followed by two screening visits. 609 participants were randomized; although 10 participants never attended the randomization visit and did not learn of their group assignment.

Participant milestones

Participant milestones
Measure
Control Group
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Overall Study
STARTED
202
200
197
Overall Study
Month 4 Visit
197
192
187
Overall Study
Year 1 Visit
187
172
183
Overall Study
Year 2 Visit
178
172
174
Overall Study
Year 3 Visit
139
125
126
Overall Study
Year 4 Visit
38
33
30
Overall Study
COMPLETED
202
200
197
Overall Study
NOT COMPLETED
0
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Study of Novel Approaches for Prevention

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Control Group
n=202 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=200 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=197 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Total
n=599 Participants
Total of all reporting groups
Age, Customized
Age · Age : 18-24 years
53 Participants
n=99 Participants
60 Participants
n=107 Participants
56 Participants
n=206 Participants
169 Participants
n=7 Participants
Age, Customized
Age · Age : 25-35 years
149 Participants
n=99 Participants
140 Participants
n=107 Participants
141 Participants
n=206 Participants
430 Participants
n=7 Participants
Sex: Female, Male
Female
158 Participants
n=99 Participants
157 Participants
n=107 Participants
154 Participants
n=206 Participants
469 Participants
n=7 Participants
Sex: Female, Male
Male
44 Participants
n=99 Participants
43 Participants
n=107 Participants
43 Participants
n=206 Participants
130 Participants
n=7 Participants
Race/Ethnicity, Customized
Race/Ethnicity · African American
19 Participants
n=99 Participants
25 Participants
n=107 Participants
22 Participants
n=206 Participants
66 Participants
n=7 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Non-Hispanic white
148 Participants
n=99 Participants
146 Participants
n=107 Participants
144 Participants
n=206 Participants
438 Participants
n=7 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Asian/Pacific Islander
7 Participants
n=99 Participants
11 Participants
n=107 Participants
7 Participants
n=206 Participants
25 Participants
n=7 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Hispanic
15 Participants
n=99 Participants
10 Participants
n=107 Participants
21 Participants
n=206 Participants
46 Participants
n=7 Participants
Race/Ethnicity, Customized
Race/Ethnicity · Multiple/Refused
13 Participants
n=99 Participants
8 Participants
n=107 Participants
3 Participants
n=206 Participants
24 Participants
n=7 Participants
BMI
<25.0 kg/m2
97 Participants
n=99 Participants
84 Participants
n=107 Participants
96 Participants
n=206 Participants
277 Participants
n=7 Participants
BMI
>=25.0 kg/m2
105 Participants
n=99 Participants
116 Participants
n=107 Participants
101 Participants
n=206 Participants
322 Participants
n=7 Participants
Weight
71.4 kilograms
STANDARD_DEVIATION 10.2 • n=99 Participants
71.9 kilograms
STANDARD_DEVIATION 11.0 • n=107 Participants
70.8 kilograms
STANDARD_DEVIATION 11.0 • n=206 Participants
71.4 kilograms
STANDARD_DEVIATION 10.7 • n=7 Participants
Education
Not college graduate
39 Participants
n=99 Participants
46 Participants
n=107 Participants
35 Participants
n=206 Participants
120 Participants
n=7 Participants
Education
College graduate
163 Participants
n=99 Participants
154 Participants
n=107 Participants
162 Participants
n=206 Participants
479 Participants
n=7 Participants
Employment Status
Employed full time
127 Participants
n=99 Participants
125 Participants
n=107 Participants
125 Participants
n=206 Participants
377 Participants
n=7 Participants
Employment Status
Student full time
49 Participants
n=99 Participants
61 Participants
n=107 Participants
55 Participants
n=206 Participants
165 Participants
n=7 Participants
Employment Status
Other
26 Participants
n=99 Participants
14 Participants
n=107 Participants
17 Participants
n=206 Participants
57 Participants
n=7 Participants

PRIMARY outcome

Timeframe: 3 years

Mean weight change from baseline across an average planned follow-up of three years. These mean changes will be compared among the three arms of the trial.

Outcome measures

Outcome measures
Measure
Control Group
n=202 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=200 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=197 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Weight Changes From Baseline Over Follow-up.
0.26 kilograms
Standard Error 0.22
-0.56 kilograms
Standard Error 0.22
-2.37 kilograms
Standard Error 0.22

SECONDARY outcome

Timeframe: 3 years

Average over time (average follow-up of 3 years) of the percent of participants within each arm of the trial who gain 1 pound or more at each visit. These percentages will be compared among the three arms generalized estimating equations. Note that weight changes in units of pounds were used to define this outcome so that it may be more clear to participants. Elsewhere in the protocol, weight is reported in kilograms. Percentages at each visit are the percent who gained 1 pound or more from baseline among all who were weighed at that visit. Participants were assigned values of 0 or 1 at each visit depending on their weight gain status.

Outcome measures

Outcome measures
Measure
Control Group
n=202 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=200 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=197 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Weight Gain 1 Pound or More at Any Time Over Follow-up
40.8 percentage gaining 1 pound or more among
Standard Error 4.4
32.5 percentage gaining 1 pound or more among
Standard Error 3.8
23.6 percentage gaining 1 pound or more among
Standard Error 2.8

SECONDARY outcome

Timeframe: 2 years

Mean differences in weight changes among intervention groups at 24 months post-randomization

Outcome measures

Outcome measures
Measure
Control Group
n=202 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=200 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=197 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Mean Weight Changes
0.54 kilograms
Standard Error 0.33
-0.77 kilograms
Standard Error 0.33
-1.50 kilograms
Standard Error 0.34

SECONDARY outcome

Timeframe: Measured at 2 Years

Population: All participants with measurements at Year 2

Compare changes in systolic blood pressure across the three intervention groups

Outcome measures

Outcome measures
Measure
Control Group
n=158 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=154 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Mean Changes in Systolic Blood Pressure
1.73 mmHg
Standard Error 0.69
-3.72 mmHg
Standard Error 0.70
-2.66 mmHg
Standard Error 0.69

SECONDARY outcome

Timeframe: 2 years

Population: All participants providing data at 2 years

Change from baseline to 2 years in diastolic blood pressure

Outcome measures

Outcome measures
Measure
Control Group
n=158 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=154 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Mean Changes From Baseline in Diastolic Blood Pressure
-0.41 mmHg
Standard Error 0.51
-2.14 mmHg
Standard Error 0.52
-1.33 mmHg
Standard Error 0.51

SECONDARY outcome

Timeframe: 2 years

Population: All participants with Year 2 measures

Mean changes from baseline to 2 years in total cholesterol among participants with Year 2 measurements (mg/dl)

Outcome measures

Outcome measures
Measure
Control Group
n=158 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=154 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Mean Changes From Baseline to 2 Years in Total Cholesterol
-0.56 mg/dl
Standard Error 1.75
0.74 mg/dl
Standard Error 1.73
1.33 mg/dl
Standard Error 1.75

SECONDARY outcome

Timeframe: 3 years

Percentage of those participants whose body mass index at baseline was less than 30 kg/m2 who subsequently transitioned to a body mass index of 30 kg/m2 or more (i.e. met criteria for obesity) sometime during 3 years of follow-up (i.e. at least one visit). Percentages will be compared among the three arms of the trial and summarized with odds ratios Participants were assigned values of 0 or 1 at each exam depending on their obesity level. Inference is based on generalized estimating equations.

Outcome measures

Outcome measures
Measure
Control Group
n=195 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=195 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=193 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Obesity
16.9 percentage of participants
Standard Error 2.7
7.9 percentage of participants
Standard Error 2.0
8.6 percentage of participants
Standard Error 2.0

SECONDARY outcome

Timeframe: 2 years

The Eating Inventory (Stunkard, 1988) is a 51-item self-report instrument, was used to assess the subscale of dietary restraint (e.g., degree of conscious control exerted over eating behaviors; range from 0-21 with higher scores reflecting greater levels of restraint). Reference: Stunkard, A. J. M., S. (1988). Eating Inventory Manual. New York: Psychological Corporation.

Outcome measures

Outcome measures
Measure
Control Group
n=178 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=172 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=174 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Dietary Restraint: Mean Change From Baseline to 2 Years
0.39 Units on a scale
Standard Error 0.18
0.59 Units on a scale
Standard Error 0.19
1.27 Units on a scale
Standard Error 0.19

SECONDARY outcome

Timeframe: Changes at 2 years

The Eating Inventory (TFEQ(Stunkard, 1988), a 51-item self-report instrument, was used to assess the subscale of disinhibition (e.g., susceptibility to loss of control over eating; range 0-16, with higher scores reflecting greater levels of disinhibition). REF: Stunkard, A. J. M., S. (1988). Eating Inventory Manual. New York: Psychological Corporation.

Outcome measures

Outcome measures
Measure
Control Group
n=178 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=172 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=174 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Disinhibition
0.07 Units on a scale
Standard Error 0.17
-0.78 Units on a scale
Standard Error 0.17
-0.03 Units on a scale
Standard Error 0.17

SECONDARY outcome

Timeframe: Changes from baseline to 2 years

Flexible control is characterized by a balanced approach to eating (e.g., taking smaller portions to control weight, engaging in healthy compensation) and is associated with better weight management outcomes (Westenhoefer, Stunkard, \& Pudel, 1999). Scores range from 0 to 12 with higher scores reflecting greater levels of flexible control. REF: Westenhoefer, J., Stunkard, A. J., \& Pudel, V. (1999). Validation of the flexible and rigid control dimensions of dietary restraint. Int J Eat Disord, 26(1), 53-64.

Outcome measures

Outcome measures
Measure
Control Group
n=178 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=172 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=174 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Flexible Dietary Control
0.39 units on a scale
Standard Error 0.18
0.59 units on a scale
Standard Error 0.19
1.27 units on a scale
Standard Error 0.19

SECONDARY outcome

Timeframe: Changes from baseline to 2 years

Rigid control is characterized by an all-or-nothing inflexibility around dietary rules (e.g., strict calorie counting, with guilt following if calorie-dense foods are consumed) that is associated with poor weight outcomes and more binge eating (Westenhoefer, Stunkard, \& Pudel, 1999). Scores range from 0 to 16 with higher scores reflecting greater rigid control. REF: Stunkard, A. J. M., S. (1988). Eating Inventory Manual. New York: Psychological Corporation.

Outcome measures

Outcome measures
Measure
Control Group
n=178 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=172 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=174 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Rigid Dietary Control
0.35 2 year changes in units on a scale
Standard Error 0.21
0.22 2 year changes in units on a scale
Standard Error 0.21
1.75 2 year changes in units on a scale
Standard Error 0.21

SECONDARY outcome

Timeframe: Changes from baseline to 2 years

The General Health Index, a one-item question from the CDC's Health-Related Quality of Life measure (Measuring Healthy Days, 2000) required participants to report whether in general their health is excellent (1), very good (2), good (3), fair (4), or poor (5). Lower scores denotes better outcomes. Ref: Measuring Healthy Days. (2000). Atlanta, Georgia: Centers for Disease Control and Prevention

Outcome measures

Outcome measures
Measure
Control Group
n=178 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=172 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=174 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
General Health Index
0.04 2 year changes in units on a scale
Standard Error 0.06
-0.04 2 year changes in units on a scale
Standard Error 0.06
-0.11 2 year changes in units on a scale
Standard Error 0.06

SECONDARY outcome

Timeframe: 2 years

Population: Mean changes among all participants with measurements at Year 2

Mean changes in HDL-C from baseline to year 2 in (mg/dl) for compared among the 3 arms using analysis of variance

Outcome measures

Outcome measures
Measure
Control Group
n=158 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=154 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Mean Changes in High Density Lipoprotein Cholesterol (HDL-C)
-0.09 Mean Change from Baseline in mg/dl
Standard Error 0.83
1.43 Mean Change from Baseline in mg/dl
Standard Error 0.82
2.12 Mean Change from Baseline in mg/dl
Standard Error 0.83

SECONDARY outcome

Timeframe: 2 years

Population: Mean changes from baseline among all participants with year 2 measures

Mean changes between baseline and 2 years in low density lipoprotein cholesterol: LDL-c (mg/dl)

Outcome measures

Outcome measures
Measure
Control Group
n=158 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=154 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Mean Changes in Low Density Lipoprotein Cholesterol (LDL-C)
-0.01 Mean change in LDL-C in mg/dl
Standard Error 1.46
0.16 Mean change in LDL-C in mg/dl
Standard Error 1.44
1.43 Mean change in LDL-C in mg/dl
Standard Error 1.46

SECONDARY outcome

Timeframe: 2 years

Population: All participants with measurements at 2 years

Mean change in fasting glucose from baseline to 2 years in mg/dl for all participants with year 2 measures

Outcome measures

Outcome measures
Measure
Control Group
n=158 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=154 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Mean Change in Fasting Glucose From Baseline to 2 Years
1.48 Mean change from baseline in mg/dl
Standard Error 0.49
0.40 Mean change from baseline in mg/dl
Standard Error 0.49
-0.18 Mean change from baseline in mg/dl
Standard Error 0.48

SECONDARY outcome

Timeframe: 2 years

Mean change in fasting insulin (uU/ml) from baseline to 2 years

Outcome measures

Outcome measures
Measure
Control Group
n=158 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=154 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Mean Change in Fasting Insulin From Baseline to 2 Years
-0.27 Mean changes at 2 years in uU/ml
Standard Error 0.33
-0.73 Mean changes at 2 years in uU/ml
Standard Error 0.33
-1.48 Mean changes at 2 years in uU/ml
Standard Error 0.32

SECONDARY outcome

Timeframe: 2 years

Population: All Participants with 2 year data

Mean changes in the Center for Epidemiologic Studies Depression (CES-C) Scale. Reference: Turvey, C. L., Wallace, R. B., \& Herzog, R. (1999). A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly. Int Psychogeriatr, 11(2), 139-148. 20 item questionnaire with a possible range of scores is zero to 60, and higher scores indicating the presence of more symptomatology.

Outcome measures

Outcome measures
Measure
Control Group
n=178 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=172 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=174 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Depression Symptomatology
1.68 units on a scale
Standard Error 0.50
0.60 units on a scale
Standard Error 0.51
1.73 units on a scale
Standard Error 0.51

SECONDARY outcome

Timeframe: Change from baseline to 2 years

We calculated homeostatic model assessment insulin resistance (HOMA-IR): fasting glucose in (mg/dl) \* fasting insulin in (uU/mL).

Outcome measures

Outcome measures
Measure
Control Group
n=158 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=154 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Insulin Resistance
-0.03 HOMA-IR
Standard Error 0.08
-0.15 HOMA-IR
Standard Error 0.08
-0.33 HOMA-IR
Standard Error 0.08

SECONDARY outcome

Timeframe: Changes from baseline to 2 years in kilocalories

Dietary intake was assessed using the 2005 Block Food Frequency Questionnaire (Block FFQ) at baseline and 2 years. This validated, quantitative 110-food item questionnaire is designed to assess relative intake of energy. REF: Block G, Woods M, Potosky A, Clifford C. Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 1990; 43:1327-1335.

Outcome measures

Outcome measures
Measure
Control Group
n=167 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=162 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Total Energy Dietary Intake Per Day (Kcals)
-134 kilocalories
Standard Error 40
-186 kilocalories
Standard Error 41
-185 kilocalories
Standard Error 41

SECONDARY outcome

Timeframe: Change from baseline to 2 years

Waist circumference will be measured using a Gulik tape measure and following a standardized protocol. Two measures of waist circumference will be taken; if the difference exceeds 1.0 cm, a third measure will be taken. Changes are measured from baseline to year 2.

Outcome measures

Outcome measures
Measure
Control Group
n=159 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=154 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=159 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Change in Waist Circumference (cm)
0.21 centimeters
Standard Error 0.46
-1.06 centimeters
Standard Error 0.47
-2.21 centimeters
Standard Error 0.46

SECONDARY outcome

Timeframe: 2 years

Number of days per week the participant reports weighing themselves. This is divided into two groups: 1) more than once per week and 2) no more than once per week

Outcome measures

Outcome measures
Measure
Control Group
n=152 Participants
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=145 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=153 Participants
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-weighing
30 Participants
44 Participants
56 Participants

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 years

Changes from baseline to year 6 in body weight

Outcome measures

Outcome data not reported

Adverse Events

Control Group

Serious events: 4 serious events
Other events: 119 other events
Deaths: 0 deaths

Self-regulation With Small Behavior Changes

Serious events: 11 serious events
Other events: 118 other events
Deaths: 0 deaths

Self-regulation With Large Behavior Changes

Serious events: 9 serious events
Other events: 109 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Control Group
n=202 participants at risk
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=200 participants at risk
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=197 participants at risk
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Musculoskeletal and connective tissue disorders
Musculoskeletal
0.50%
1/202 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
1.0%
2/200 • Number of events 2 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/197 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Gastrointestinal disorders
Gall bladder
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
1.5%
3/200 • Number of events 3 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.51%
1/197 • Number of events 2 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Psychiatric disorders
Psychiatric
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/200 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
1.5%
3/197 • Number of events 6 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Pregnancy, puerperium and perinatal conditions
Obstetric
0.99%
2/202 • Number of events 2 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
1.5%
3/200 • Number of events 3 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/197 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
General disorders
Motor Vehicle Accident
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.50%
1/200 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/197 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Infections and infestations
Tonsillectomy
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/200 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.51%
1/197 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Infections and infestations
E-coli bacterial infection
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/200 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.51%
1/197 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
General disorders
Elective breast surgery
0.50%
1/202 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/200 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/197 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Gastrointestinal disorders
Stomach virus
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.50%
1/200 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/197 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
General disorders
Benign mass
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/200 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.51%
1/197 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
General disorders
Syncope
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/200 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.51%
1/197 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Gastrointestinal disorders
Crohn's disease
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/200 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.51%
1/197 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Musculoskeletal and connective tissue disorders
Arthritis
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.50%
1/200 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/197 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.

Other adverse events

Other adverse events
Measure
Control Group
n=202 participants at risk
"Self-Guided Behavior Changes". This group will be used to determine average rate of weight gain over 3 years with little intervention. Participants randomized to this group will receive one face-to-face session that will provide general education of self-weighing and information about both the small and large changes approach. Participants will also be provided with quarterly newsletters describing study events and very limited information on health eating.
Self-regulation With Small Behavior Changes
n=200 participants at risk
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate small changes (e.g., modify diet by approximately 100 kcal, decrease portion sizes or change types of food, increase activity by 2000 steps/day). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Self-regulation With Large Behavior Changes
n=197 participants at risk
Participants randomized to this group will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate large changes (e.g., modify diet to 1200-1500 or 1500-1800 kcal/day with \< 30% fat, increase exercise to 250 minutes/week of moderate intensity activity). Self-regulation theory: Participants randomized to either of these two groups will be taught to self-weigh daily and report weights regularly. They will be reinforced for maintaining weight below randomization weight and taught that if weight exceeds randomization weight, they should reinstate either large or small changes.
Cardiac disorders
Cardiovascular
1.5%
3/202 • Number of events 3 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
3.5%
7/200 • Number of events 7 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
3.6%
7/197 • Number of events 7 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Musculoskeletal and connective tissue disorders
Muscoskeletal
27.2%
55/202 • Number of events 65 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
25.0%
50/200 • Number of events 63 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
22.8%
45/197 • Number of events 51 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Endocrine disorders
Diabetes
0.99%
2/202 • Number of events 3 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.50%
1/200 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.00%
0/197 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Gastrointestinal disorders
Gall bladder
0.50%
1/202 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.50%
1/200 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.51%
1/197 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Psychiatric disorders
Psychiatric
7.9%
16/202 • Number of events 17 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
9.0%
18/200 • Number of events 20 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
8.1%
16/197 • Number of events 18 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Respiratory, thoracic and mediastinal disorders
Ashthma Attack
0.00%
0/202 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.50%
1/200 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
1.0%
2/197 • Number of events 2 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Pregnancy, puerperium and perinatal conditions
Obstetric
7.4%
15/202 • Number of events 21 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
6.5%
13/200 • Number of events 15 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
5.1%
10/197 • Number of events 13 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
Metabolism and nutrition disorders
Weight loss related
0.50%
1/202 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.50%
1/200 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
0.51%
1/197 • Number of events 1 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
General disorders
Motor vehicle accident
12.9%
26/202 • Number of events 30 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
14.0%
28/200 • Number of events 31 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
13.7%
27/197 • Number of events 30 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
General disorders
Other
27.7%
56/202 • Number of events 68 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
20.0%
40/200 • Number of events 48 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.
27.4%
54/197 • Number of events 64 • Adverse Event Data were collected on all participants from the time the participant signed the consent throughout the duration of the study (an average follow-up of 3 years). Participants were asked at each visit (scheduled to occur at months 4, 12, 24, 36, and 48 depending on when participants were enrolled relative to the end of follow-up) to report any medical events that occurred. Participants were also allowed to contact the clinic staff to report an adverse events at any intervening time
Participants were asked about hospitalizations and any medical events at each study visit (4 months, 1 year, annually thereafter). Participants could also contact the study staff between visits to report an adverse event.

Additional Information

Mark Espeland

Wake Forest University School of Medicine

Phone: 336-716-2826

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place